These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36723668)

  • 21. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
    Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
    Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
    Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
    Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
    Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
    J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of astrocyte-elevated gene-1 indicates prognostic value of fluoropyrimidine-based adjuvant chemotherapy in resectable stage III colorectal cancer.
    Lin LW; Lai PS; Chen YY; Chen CY
    Pathol Int; 2021 Nov; 71(11):752-764. PubMed ID: 34528330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
    Park HS; Jung M; Shin SJ; Heo SJ; Kim CG; Lee MG; Beom SH; Lee CY; Lee JG; Kim DJ; Ahn JB
    Ann Surg Oncol; 2016 Mar; 23(3):928-35. PubMed ID: 26514121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of interaction between somatic APC mutations and 5-fluorouracil adjuvant chemotherapy in Taiwanese colorectal cancer subjects.
    Chen SP; Wu CC; Lin SZ; Kang JC; Su CC; Chen YL; Lin PC; Chiu SC; Pang CY; Harn HJ
    Am J Clin Oncol; 2009 Apr; 32(2):122-6. PubMed ID: 19307944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
    Bruun J; Sveen A; Barros R; Eide PW; Eilertsen I; Kolberg M; Pellinen T; David L; Svindland A; Kallioniemi O; Guren MG; Nesbakken A; Almeida R; Lothe RA
    Mol Oncol; 2018 Sep; 12(9):1639-1655. PubMed ID: 29900672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Energy balance-related factors in childhood and adolescence and risk of colorectal cancer expressing different levels of proteins involved in the Warburg-effect.
    Jenniskens JCA; Offermans K; Simons CCJM; Samarska I; Fazzi GE; Smits KM; Schouten LJ; Weijenberg MP; Grabsch HI; van den Brandt PA
    Int J Cancer; 2022 Jun; 150(11):1812-1824. PubMed ID: 35064924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
    Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
    Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.
    Gormley JA; Hegarty SM; O'Grady A; Stevenson MR; Burden RE; Barrett HL; Scott CJ; Johnston JA; Wilson RH; Kay EW; Johnston PG; Olwill SA
    Br J Cancer; 2011 Nov; 105(10):1487-94. PubMed ID: 21989182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
    Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
    Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
    Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
    World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Principles of oncologic drug therapy following surgery for bowel cancer].
    Ristamäki R; Ålgars A
    Duodecim; 2016; 132(12):1155-9. PubMed ID: 27483631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
    Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M
    Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma.
    Buhmeida A; Bendardaf R; Hilska M; Laine J; Collan Y; Laato M; Syrjänen K; Pyrhönen S
    Ann Oncol; 2009 Jul; 20(7):1230-5. PubMed ID: 19276398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II-III Colorectal Cancer.
    Wang Z; Xing K; Zhang B; Zhang Y; Chai T; Geng J; Qin X; Zhang X; Xu C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
    Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y
    Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and survival analysis of 837 Chinese colorectal cancer patients.
    Yuan Y; Li MD; Hu HG; Dong CX; Chen JQ; Li XF; Li JJ; Shen H
    World J Gastroenterol; 2013 May; 19(17):2650-9. PubMed ID: 23674872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
    Riedl JM; Posch F; Bezan A; Szkandera J; Smolle MA; Winder T; Rossmann CH; Schaberl-Moser R; Pichler M; Stotz M; Stöger H; Gerger A
    BMC Cancer; 2017 Jun; 17(1):415. PubMed ID: 28619086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
    Wang Z; Jiang B; Chen L; Di J; Cui M; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Dong B; Ji J; Su X
    J Transl Med; 2014 Jan; 12():15. PubMed ID: 24444035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.